Mark Enyedy - 30 Jun 2021 Form 4 Insider Report for ImmunoGen, Inc. (IMGN)

Role
Chief Executive Officer, Director
Signature
/s/ Joseph J. Kenny, attorney in fact
Issuer symbol
IMGN
Transactions as of
30 Jun 2021
Net transactions value
+$21,246
Form type
4
Filing time
02 Jul 2021, 16:21:15 UTC
Previous filing
14 Jun 2021
Next filing
08 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Award $21,246 +3,849 +0.9% $5.52 432,866 30 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from January 1, 2021 through June 30, 2021.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 4, 2021.